Rizatriptan Benzoate
- Product NDC
- 53002-1713
- 11-digit product format
- 530021713
- Labeler code
- 53002
- Product ID
- 53002-1713_67f55b41-eb9b-4568-b162-d7e7c1df64ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA204339
- Marketing category
- ANDA
- Marketing start
- 2016-07-22
- Marketing end
- 0000-00-00
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1713-1 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET | 3 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1713 | RIZATRIPTAN BENZOATE TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 1 package rows | 20230609_6535f200-ffa3-4564-972c-3bdadcde4a9b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1713-1 | 53002171301 | 3 TABLET in 1 CARTON (53002-1713-1) | 3 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |